Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.55 USD | -0.09% | +0.19% | +0.35% |
04-18 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
04-18 | Cerevel Therapeutics' Potential Parkinson's Treatment Meets Primary Endpoint in Phase 3 Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.35% | 7.73B | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- CERE Stock
- News Cerevel Therapeutics Holdings, Inc.
- Cerevel Therapeutics : Jefferies & Co Adjusts Cerevel Therapeutics Holdings PT to $22 From $18, Maintains Buy Rating